In the shadowed caves of ancient India, Siddhartha Gautama sat under a bodhi tree, wrestling with the hydra-headed beast of desire
[76] [77] In a 72-week, phase IIIb open-label head-to-head trial of adults with obesity without diabetes, tirzepatide at the maximum tolerated dose produced greater mean weight loss than semaglutide and larger reductions in waist circumference, while gastrointestinal adverse events were the most common with both drugs
When a cold already suppresses your desire to eat, this combined effect can make consuming adequate nutrition and hydration difficultexactly when your immune system needs fuel to fight infection
Whilst both berberine and GLP-1 agonists may influence glucose metabolism and body weight, they achieve these effects through entirely different pharmacological pathways
Questions: Please reach out to your Medical Provider at your clinic
JCI Insight 5(17):e140532 Killion EA, Wang J, Yie J, Shi SD, Bates D, Min X et al (2018) Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models